Bevacizumab and abdominal pain Patient Reports February 10, 2012

Bevacizumab Side Effects Report #4872530-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 30, 2005. Male patient, weighting 182.0 lb, was diagnosed with transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, intestinal perforation. Bevacizumab dosage: 15 MG PER KG Q 3 WKS IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5354555-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2007. Male patient, weighting 184.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , constipation , dehydration, diverticulitis. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, FLUOROURACIL, WELLBUTRIN, DIGITEK, ZOCOR, INSULIN, ACTOS. Patient was hospitalized. Patient died on 05/18/2007.

Bevacizumab Side Effects Report #5366991-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 15, 2007. Male patient, weighting 184.0 lb, was diagnosed with squamous cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , constipation , dehydration, diverticulitis. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, FLUOROURACIL, WELLBUTRIN, DIGITEK, ZOCOR, INSULIN, ACTOS. Patient was hospitalized. Patient died on 05/18/2007.

Bevacizumab Side Effects Report #5736121-0
Bevacizumab side effect was reported by a Consumer or non-health professional from GERMANY on Apr 29, 2008. Male patient, weighting 163.1 lb, was diagnosed with renal cell carcinoma, renal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , multi-organ failure. Bevacizumab dosage: 1140 MG, Q3W. During the same period patient was treated with INTERFERON ALFA, VINBLASTINE SULPHATE, METOCLOPRAMIDE HYDROCHLORIDE, ACETAMINOPHEN, RAMIPRIL, ALLOPURINOL, NEORECORMON, MICARDIS HCT. Patient was hospitalized. Patient died on 04/11/2008.


Bevacizumab Side Effects Report #5755242-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 29, 2008. Female patient, weighting 104.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , refusal of treatment by patient. Bevacizumab dosage: 713 MG Q/ 21 DAYS IV. During the same period patient was treated with BERTOZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5757015-0
Bevacizumab side effect was reported by a Consumer or non-health professional from GERMANY on May 19, 2008. Male patient, weighting 163.1 lb, was diagnosed with renal cell carcinoma, renal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , multi-organ failure. Bevacizumab dosage: 1140 MG, Q3W. During the same period patient was treated with INTERFERON ALFA, VINBLASTINE SULPHATE, METOCLOPRAMIDE HYDROCHLORIDE, ACETAMINOPHEN, RAMIPRIL, ALLOPURINOL, NEORECORMON, MICARDIS HCT. Patient was hospitalized. Patient died on 04/11/2008.

Bevacizumab Side Effects Report #5765289-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypertension, hypothyroidism, nausea . Bevacizumab dosage: 15 MG/KG (690 MG) Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5782995-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , refusal of treatment by patient, treatment noncompliance. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5852385-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Male patient, weighting 114.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , chest pain , chronic obstructive pulmonary disease, diarrhoea, metastasis. Bevacizumab dosage: 15 MG/KG (777MG) Q 21 DAYS IV. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5852586-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , refusal of treatment by patient. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6021215-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Female patient, weighting 106.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , blood glucose increased, dizziness , nausea , pancreatic insufficiency. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5317435-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 03, 2007. Female patient, 49 years of age, weighting 135.0 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , chapped lips, cheilitis, diarrhoea, enteritis, flatulence, heart rate increased, lip dry, nausea . Bevacizumab dosage: 5MG/KG IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5558176-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , enteritis, ileus. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.

Bevacizumab Side Effects Report #6086391-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Female patient, weighting 122.2 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , large intestine perforation, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with FLUOROURACIL, METOPROLOL SUCCINATE, WARFARIN, MORPHINE, ONDANSETRON, PROMETHAZINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6102460-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 25, 2009. Female patient, weighting 122.2 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , large intestine perforation, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with FLUOROURACIL, METOPROLOL SUCCINATE, WARFARIN, MORPHINE, ONDANSETRON, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.

Bevacizumab Side Effects Report #5993242-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 10, 2008. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , neurogenic bladder, obstruction gastric. Bevacizumab dosage: 690MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6060382-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2009. Male patient, 70 years of age, weighting 191.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , device breakage, device migration, enterocolitis infectious, large intestine perforation, post procedural discomfort, pyrexia. Bevacizumab dosage: 690MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #6100545-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2009. Male patient, 70 years of age, weighting 191.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , device breakage, device migration, enterocolitis infectious, gastrointestinal haemorrhage, large intestine perforation, post procedural complication. Bevacizumab dosage: 690MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient died on 02/24/2009.


Bevacizumab Side Effects Report #5132580-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2006. Male patient, 63 years of age, weighting 160.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , incision site oedema, incisional drainage, wound dehiscence. Bevacizumab dosage: 764 MG Q 2 WEEKS IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5164856-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 10, 2006. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, diffuse alveolar damage, lethargy, malaise, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LISINOPRIL, DICLOFENAC, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #4999871-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 21, 2006. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, diffuse alveolar damage, hypertension, lethargy, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LISINOPRIL. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5382905-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 26, 2007. Female patient, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, body temperature increased. Bevacizumab dosage: 340 MG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, GAVISCON, LISINOPRIL, DICLOFENAC, PARACETAMOL. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5398344-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 13, 2007. Female patient, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, body temperature increased. Bevacizumab dosage: 340 MG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, GAVISCON, LISINOPRIL, DICLOFENAC, ACETAMINOPHEN, OMEPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 03/10/2006.


Bevacizumab Side Effects Report #5463067-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 05, 2007. Female patient, weighting 149.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, lethargy, malaise, metabolic acidosis, pyrexia, sinus tachycardia. Bevacizumab dosage: 340 MG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, GAVISCON, LISINOPRIL, DICLOFENAC, PARACETAMOL, OMEPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 03/10/2006.

Bevacizumab Side Effects Report #5727586-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 01, 2008. Male patient, weighting 176.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , aneurysm ruptured. Bevacizumab dosage: 840 MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient died on 04/04/2008.

Bevacizumab Side Effects Report #5734163-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 31, 2007. Male patient, 71 years of age, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with XELODA, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5603057-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 16, 2008. Male patient, weighting 180.3 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , cholecystitis. Bevacizumab dosage: unknown. During the same period patient was treated with GEMZAR, PROTONIX, GLUCOPHAGE, ZOFRAN, VICODIN, ZOCOR, ASPIRIN, LANTUS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5649791-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia, vomiting. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, CAPECITABINE, GEMCITABINE, DICLOFENAC, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5812192-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 01, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , neuropathy peripheral, small intestinal obstruction. Bevacizumab dosage: 425 MG, UNK. During the same period patient was treated with CARBOPLATIN, TAXOL, HALOPERIDOL, OXYCODONE, DOCUSATE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5949168-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea. Bevacizumab dosage: 623 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LERCANIDIPINE. Patient was hospitalized. Patient died on 10/13/2008.

Bevacizumab Side Effects Report #6033191-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 23, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain . Bevacizumab dosage: 345 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ZOLPIDEM, VENLAFAXINE, ESOMEPRAZOLE MAGNESIUM, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2008.

Bevacizumab Side Effects Report #6057855-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 16, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain . Bevacizumab dosage: 345 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ZOLPIDEM, VENLAFAXINE, ESOMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2008.

Bevacizumab Side Effects Report #6065604-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , neuropathy peripheral, small intestinal obstruction. Bevacizumab dosage: 425 MG, UNK. During the same period patient was treated with CARBOPLATIN, TAXOL, HALOPERIDOL, OXYCODONE, DOCUSATE, LANSOPRAZOLE, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6074230-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 27, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , lymphocele, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6084466-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 04, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain . Bevacizumab dosage: 375 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ZOLPIDEM, VENLAFAXINE, ESOMEPRAZOLE MAGNESIUM, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2008.

Bevacizumab Side Effects Report #5728617-2
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 02, 2008. Female patient, 59 years of age, weighting 158.7 lb, was diagnosed with ovarian cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , constipation , large intestine perforation, peritonitis. Bevacizumab dosage: 10MG/KG, 740MG EVERY 14 DAY IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4743058-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 28, 2005. Female patient, 71 years of age, weighting 103.8 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , abscess intestinal, ascites, blood albumin decreased, chills, gastrointestinal infection, gastrointestinal neoplasm, gastrointestinal perforation. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with REGLAN, ZOFRAN, COZAAR, ASPIRIN, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4867530-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 19, 2005. Female patient, 71 years of age, weighting 123.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal pain , blood creatinine decreased, blood sodium decreased, decreased appetite, enterococcal infection, fistula , gastric dilatation. Bevacizumab dosage: 840 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, VICODIN, VITAMIN C, CALCIUM. Patient was hospitalized. Patient died on 11/05/2005.


Bevacizumab Side Effects Report #4778294-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time prolonged, adhesion , ascites, atelectasis, atrial fibrillation , blood creatine phosphokinase increased, blood creatinine increased, blood lactic acid decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, DOCUSATE, SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4905345-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 20, 2006. Female patient, 39 years of age, weighting 226.9 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain lower, anal fistula, body temperature increased, decreased appetite, diarrhoea, heart rate increased, nausea . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, ASPIRIN, ATIVAN, LIPITOR, LOPRESSOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5599815-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , convulsion, hydronephrosis, inadequate analgesia, malignant neoplasm progression, sepsis . Bevacizumab dosage: 10 MG/KG INTRAVENOUS DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, EPIDURAL, DIPHENHYDRAMINE, ERTAPENEM. Patient died on 01/09/2008.

Bevacizumab Side Effects Report #5656910-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 210 MG, UNK. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5696340-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5819205-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 14, 2008. Female patient, weighting 221.6 lb, was diagnosed with ovarian cancer, pain , constipation , vitamin supplementation, nausea , diarrhoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, ADVIL, MILK OF MAGNESIA, VITAMIN E, ZOFRAN, PHENERGAN, LORTAB, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4866580-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 06, 2005. Male patient, 50 years of age, weighting 190.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , atelectasis, blood alkaline phosphatase increased, blood pressure decreased, bronchopneumonia, cardiac arrest , decreased appetite, gastrointestinal haemorrhage, gastrointestinal neoplasm. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5004595-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 01, 2006. Male patient, 50 years of age, weighting 190.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , atelectasis, blood alkaline phosphatase increased, blood pressure decreased, bronchopneumonia, cardio-respiratory arrest, chest pain , cough, decreased appetite. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died on 09/26/2005.

Bevacizumab Side Effects Report #5027164-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, 39 years of age, weighting 242.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dehydration, dysphagia, vomiting. Bevacizumab dosage: 5 MG/KG, DAYS 1 + 15, INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5025139-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 03, 2006. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, back pain , blood alkaline phosphatase increased, blood sodium decreased, decreased appetite, depression . Bevacizumab dosage: 1238 MG. During the same period patient was treated with GEMZAR, CAROPLATN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5821247-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 22, 2008. Male patient, 67 years of age, weighting 187.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , decreased appetite, metastases to pancreas, nausea , weight decreased. Bevacizumab dosage: 15 MG/KG ONCE EVERY 3 WEEKS IV DRIP. During the same period patient was treated with BORTEZOMIB MILLENNIUM, LISINOPRIL, ACTOS, METOPROLOL SUCCINATE, GLIMEPIRIDE, ISOSORBIDE DINITRATE, GLIPIZIDE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4691189-8
Bevacizumab side effect was reported by a Physician from on June 01, 2005. Male patient, 46 years of age, weighting 209.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain upper, back pain , bacteria sputum identified, bacteria urine identified, bacterial infection , blood albumin decreased, blood lactate dehydrogenase increased, carcinoembryonic antigen increased. Bevacizumab dosage: 1418 MG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, LIPITOR, LASIX, COREG, PRINIVIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5301509-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.

Bevacizumab Side Effects Report #5312790-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.

Bevacizumab Side Effects Report #5326628-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 01, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , fatigue, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5736839-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 31, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , gastritis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CETUXIMAB, PACLITAXEL, CARBOPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4993515-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient, weighting 169.1 lb, was diagnosed with neuroendocrine tumour, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , aortic thrombosis, back pain , blood pressure increased, chest pain , dyspnoea, vomiting. Bevacizumab dosage: 375 MG QS Q 2 WEEKS IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5225749-2
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 31, 2007. Male patient, 63 years of age, weighting 149.0 lb, was diagnosed with neoplasm malignant, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , flatulence, haemoptysis, pneumonia , purulence. Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS. During the same period patient was treated with BUBBLE GUM ENEMA, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5320860-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 30, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diverticulitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FLUOROURACIL, DIGOXIN, FAMOTIDINE, MEROPENEM, FLAGYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5325709-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diverticular perforation, diverticulitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FLUOROURACIL, DIGOXIN, FAMOTIDINE, MEROPENEM, FLAGYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5333436-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 17, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diverticular perforation, diverticulitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FLUOROURACIL, DIGOXIN, FAMOTIDINE, MEROPENEM, FLAGYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5340542-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 23, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diverticular perforation, diverticulitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FLUOROURACIL, DIGOXIN, FAMOTIDINE, MEROPENEM, FLAGYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5363001-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 14, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diverticular perforation, diverticulitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FLUOROURACIL, DIGOXIN, FAMOTIDINE, MEROPENEM, FLAGYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4594920-5
Bevacizumab side effect was reported by a Health Professional from on Feb 01, 2005. Female patient, 55 years of age, was diagnosed with metastatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , caecitis, colitis, large intestine perforation, pneumonia , serositis. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5967955-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Female patient, 47 years of age, weighting 107.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , catheter site related reaction, cellulitis , gastrointestinal stoma complication, nausea , neutropenia, secretion discharge. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, COLACE, LUNESTA, OMEPRAZOLE, TRAMADOL, VITAMIN B, COMPAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5324283-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 04, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5328627-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6106448-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2009. Male patient, weighting 117.1 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, disease progression, loss of consciousness, nausea , weight decreased. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, MS CONTIN, OXALIPLATIN, TYLENOL W. Patient was hospitalized. Patient died on 02/21/2009.

Bevacizumab Side Effects Report #6008478-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , lymphopenia. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTERFERON ALFA, INTERFERON ALFA. Patient recovered.

Bevacizumab Side Effects Report #6024066-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 23, 2008. Male patient was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , lymphopenia. Bevacizumab dosage: 15 MG/KG, Q14D. During the same period patient was treated with INTERFERON ALFA, INTERFERON ALFA. Patient recovered.


Bevacizumab Side Effects Report #5989724-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , mucosal inflammation, platelet count decreased. Bevacizumab dosage: 10 MG/KG, DAYS 1+15, 28 DAY CYCLE. During the same period patient was treated with ERLOTINIB. Patient recovered.

Bevacizumab Side Effects Report #5879321-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2008. Male patient, weighting 332.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, glioblastoma multiforme, ileus, malignant neoplasm progression, nausea , pyrexia, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with BORTIZOMIB, PROVIGIL, TRAZODONE, KEPPRA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5749688-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Male patient, 47 years of age, was diagnosed with gastrointestinal fistula and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , fistula . Bevacizumab dosage: 325 MG Q 3W PR. During the same period patient was treated with ENOXAPARIN, THYROXIN, INSULIN. Patient recovered.

Bevacizumab Side Effects Report #5440811-7
Bevacizumab side effect was reported by a Consumer or non-health professional from DENMARK on Aug 17, 2007. Male patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal abscess, abdominal pain , gallbladder perforation. Bevacizumab dosage: 840 MG, UNK. During the same period patient was treated with ERLOTINIB, PANTOPRAZOLE, ACETAMINOPHEN, MORPHINE, IMOZOP, ROCEPHIN, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5460609-3
Bevacizumab side effect was reported by a Consumer or non-health professional from DENMARK on Sept 04, 2007. Male patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , abscess , gallbladder perforation. Bevacizumab dosage: 840 MG, UNK. During the same period patient was treated with ERLOTINIB, PANTOPRAZOLE, ACETAMINOPHEN, MORPHINE, IMOZOP, ROCEPHIN, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5595324-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 03, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , c-reactive protein increased, pyrexia, vomiting. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5596057-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 07, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , deep vein thrombosis , pyrexia. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient died on 02/25/2007.

Bevacizumab Side Effects Report #5610949-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 30, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , deep vein thrombosis , pyrexia. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient died on 02/25/2007.

Bevacizumab Side Effects Report #5610954-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 30, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , c-reactive protein increased, deep vein thrombosis , depression , disease progression, ileus, infection , pyrexia, small intestinal obstruction. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5007331-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, weighting 169.1 lb, was diagnosed with endocrine pancreatic disorder, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , aortic disorder, blood pressure diastolic decreased, chest pain , condition aggravated, dehydration, haematoma, hypertension, jejunal ulcer. Bevacizumab dosage: 37.5 MG QS, Q 2 WEEKS, IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5062789-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, weighting 190.0 lb, was diagnosed with endocrine neoplasm, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, asthenia, fatigue, gastritis erosive, ileus, liver abscess, platelet count decreased, pyrexia. Bevacizumab dosage: 465 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4698725-6
Bevacizumab side effect was reported by a Health Professional from on June 09, 2005. Female patient, 67 years of age, weighting 164.0 lb, was diagnosed with colorectal cancer metastatic, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haemoglobin decreased, lymphocyte count increased, neutropenia, pelvic abscess, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN, ZOCOR, PROPOLIS, VITAMIN, VITAMIN C. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5548016-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2007. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haematemesis, mucosal inflammation. Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5552092-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2007. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haematemesis, mucosal inflammation. Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5578427-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 13, 2007. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haematemesis, mucosal inflammation. Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient died on 11/20/2007.

Bevacizumab Side Effects Report #5834107-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 21, 2008. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haematemesis, mucosal inflammation. Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient died on 11/20/2007.

Bevacizumab Side Effects Report #5851801-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 06, 2008. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haematemesis, mucosal inflammation, sepsis . Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient died on 11/20/2007.

Bevacizumab Side Effects Report #5955256-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 03, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , pyrexia. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977504-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 20, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , peptic ulcer . Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.

Bevacizumab Side Effects Report #6084674-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 09, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , peptic ulcer . Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.

Bevacizumab Side Effects Report #6113049-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 26, 2009. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , peptic ulcer . Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.

Bevacizumab Side Effects Report #4668433-6
Bevacizumab side effect was reported by a Physician from on May 09, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal mass, abdominal pain , anorexia, back pain , colorectal cancer metastatic, deep vein thrombosis , dehydration, dizziness . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4687177-8
Bevacizumab side effect was reported by a Health Professional from on May 24, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal mass, abdominal pain , anorexia, atelectasis, back pain , blood culture positive, blood pressure decreased, body temperature increased, colorectal cancer metastatic. Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient died on 05/05/2005.

Bevacizumab Side Effects Report #5288602-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 22, 2007. Male patient, weighting 233.7 lb, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, liver function test abnormal, renal function test abnormal. Bevacizumab dosage: 700 MG, 2/WEEK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5837775-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2008. Female patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , dehydration, pyrexia. Bevacizumab dosage: 400 MG, QD. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, METOCLOPRAMIDE, LOPERAMIDE, NEXIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6023466-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 15, 2008. Female patient was diagnosed with colorectal cancer , colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , c-reactive protein increased, infection , pyrexia. Bevacizumab dosage: 509 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5655681-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 22, 2008. Female patient, 40 years of age, was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, colonic stenosis, dehydration, haemoglobin decreased. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, KYTRIL, DECADRON, MAGNESIUM OXIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5848793-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 11, 2008. Female patient, 40 years of age, was diagnosed with colon cancer recurrent, prophylaxis of nausea and vomiting and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , intestinal obstruction. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, KYTRIL, DECADRON SRC, MAGNESIUM OXIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5872837-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 22, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , neuropathy peripheral, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5929914-8
Bevacizumab side effect was reported by a Physician from JAPAN on Oct 09, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , neuropathy peripheral, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5215801-X
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 08, 2007. Female patient, 54 years of age, weighting 140.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , atelectasis, blood bilirubin increased, cardiac arrest , diarrhoea, dyspnoea, hepatic necrosis, hepatic steatosis, intestinal ischaemia. Bevacizumab dosage: 640 MG, Q3W, INTRAVENOUS. During the same period patient was treated with XELODA, DARVOCET, PHENERGAN, PROPOFOL. Patient was hospitalized. Patient died on 11/30/2006.